Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusheng Guo

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|December 16, 2025
Molecular insights into ago-allosteric modulation at cysteinyl leukotriene receptor 2Mu Li, Xiaoling Bao, Wanbiao Chen, et al.
Scientific Reports|December 14, 2020
Altered diversity and composition of gut microbiota in Wilson's diseaseXiangsheng Cai, Lin Deng, Xiaogui Ma, et al.
Frontiers in Oncology|September 29, 2022
Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective studyBo Sun, Lijie Zhang, Tao Sun, et al.
International Journal of Surgery (London, England)|June 24, 2025
Non-invasive prediction of NSCLC immunotherapy efficacy and tumor microenvironment through unsupervised machine learning-driven CT Radiomic subtypes: a multi-cohort studyYusheng Guo, Bingxin Gong, Yi Li, et al.
European Journal of Radiology|September 17, 2024
Transjugular intrahepatic portosystemic shunt (TIPS) with variceal embolization reduces rebleeding risk for patients with portal pressure gradient over 12 mmHg: A long-term follow-up studyYaowei Bai, Jiacheng Liu, Wenlong Wu, et al.
Communications Biology|January 30, 2026
Structural analysis reveals that water molecules mediate self-activation of GPR99Miaofang Xiao, Xiaoling Bao, Yusheng Guo, et al.
Frontiers in Immunology|May 3, 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitorsJie Lou, Bingxin Gong, Yi Li, et al.
NPJ Precision Oncology|March 28, 2026
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter studyYusheng Guo, Bingxin Gong, Jie Lou, et al.
Translational Lung Cancer Research|June 19, 2025
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective studyWeiwei Liu, Yusheng Guo, Peng Mo, et al.
BMC Medical Imaging|July 2, 2025
Development and validation of AI-based automatic segmentation and measurement of thymus on chest CT scansYusheng Guo, Bingxin Gong, Guowei Jiang, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|December 16, 2025
Molecular insights into ago-allosteric modulation at cysteinyl leukotriene receptor 2Mu Li, Xiaoling Bao, Wanbiao Chen, et al.
Scientific Reports|December 14, 2020
Altered diversity and composition of gut microbiota in Wilson's diseaseXiangsheng Cai, Lin Deng, Xiaogui Ma, et al.
Frontiers in Oncology|September 29, 2022
Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective studyBo Sun, Lijie Zhang, Tao Sun, et al.
International Journal of Surgery (London, England)|June 24, 2025
Non-invasive prediction of NSCLC immunotherapy efficacy and tumor microenvironment through unsupervised machine learning-driven CT Radiomic subtypes: a multi-cohort studyYusheng Guo, Bingxin Gong, Yi Li, et al.
European Journal of Radiology|September 17, 2024
Transjugular intrahepatic portosystemic shunt (TIPS) with variceal embolization reduces rebleeding risk for patients with portal pressure gradient over 12 mmHg: A long-term follow-up studyYaowei Bai, Jiacheng Liu, Wenlong Wu, et al.
Communications Biology|January 30, 2026
Structural analysis reveals that water molecules mediate self-activation of GPR99Miaofang Xiao, Xiaoling Bao, Yusheng Guo, et al.
Frontiers in Immunology|May 3, 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitorsJie Lou, Bingxin Gong, Yi Li, et al.
NPJ Precision Oncology|March 28, 2026
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter studyYusheng Guo, Bingxin Gong, Jie Lou, et al.
Translational Lung Cancer Research|June 19, 2025
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective studyWeiwei Liu, Yusheng Guo, Peng Mo, et al.
BMC Medical Imaging|July 2, 2025
Development and validation of AI-based automatic segmentation and measurement of thymus on chest CT scansYusheng Guo, Bingxin Gong, Guowei Jiang, et al.
Pageof 8